PRL and pituitary tumor: Investigation of chimeric compounds that combine both a DA moiety and a peptidic SST moiety within the same compound, and that retain the ability to potently bind both to DR and SSTR, has shown promise in suppressing secretion of growth hormone (GH) and prolactin (PRL) from functioning pituitary tumors (22, 23).